Targretin Main Life
萬聯行在香港獲得Targretin®️(Bexarotene)用於皮膚T細胞淋巴瘤的上市批准
July 16, 2024 02:54 ET | MAIN LIFE CORPORATION LIMITED
香港和澳門的獲批為Targretin®️首次在中國區域內上市Bexarotene為國際臨床慣例用於治療復發性皮膚T細胞淋巴瘤(CTCL)的標準藥物 香港, July 16, 2024 (GLOBE NEWSWIRE) --...
Targretin Main Life
万联行获得Targretin®(Bexarotene 贝沙罗汀)在香港用于皮肤T细胞淋巴瘤的市场批准
July 16, 2024 02:54 ET | MAIN LIFE CORPORATION LIMITED
香港和澳门的批准标志着Targretin®首次在中国上市贝沙罗汀代表国际临床实践中对复发性皮肤T细胞淋巴瘤(CTCL)的标准治疗 香港, July 16, 2024 (GLOBE NEWSWIRE) -- 万联行有限公司(“Main Life”)今天宣布Targretin®(贝沙罗汀)胶囊在香港获得上市许可,用于治疗至少一次系统治疗无效的皮肤T细胞淋巴瘤 (Cutaneous T-cell...
Targretin Main Life
Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma
July 16, 2024 02:54 ET | MAIN LIFE CORPORATION LIMITED
Targretin® (Bexarotene) received Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma.
sunriselogo.jpg
Sunrise New Energy Secures $13.76 Million Low-Interest Loan from CCB
June 27, 2024 09:30 ET | Sunrise New Energy Co., Ltd
Loan Enhances Liquidity to Accelerate Delivery of High-Demand Orders ZIBO, China, June 27, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise New Energy”, the “Company”, “we” or “our”)...
sunriselogo.jpg
Sunrise Secures New Key Client with Significant Order
June 25, 2024 09:30 ET | Sunrise New Energy Co., Ltd
ZIBO, China, June 25, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise New Energy”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced the acquisition of a significant new...
Logo.jpg
Towards A New Journey, Hengqin Accelerates the Cultivation of the New "Industry + Exhibition" Business Model ZHUHAI, China, June 12, 2024 (GLOBE NEWSWIRE) -- As of the end of this May, the Guangdong-Macao In-Depth Cooperation Zone in Hengqin (here in after referred to as the "Cooperation Zone") has been...
Wenzhou-Kean University Commencement 2024
Kean University Commits to Expanded International Exchanges as Wenzhou-Kean University Enters Global Spotlight
June 10, 2024 12:48 ET | Kean University
Union, N.J., June 10, 2024 (GLOBE NEWSWIRE) -- Kean University committed to expanding its international student exchange initiatives this week as senior Chinese leaders publicly lauded the...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Lasofoxifene
June 06, 2024 09:00 ET | Sermonix Pharmaceuticals Inc.
IND approval in China allows Shanghai Henlius Biotech, Sermonix’s Chinese development partner for oral lasofoxifene, to enroll ELAINE-3 trial patients in ChinaUnder strategic collaboration agreement...
David Barrett, CEO of EBC Financial Group (UK) Ltd, as one of the speakers on Yi Cai's Chief Strategy Forum on Chinese investment opportunities
Surge in Foreign Interest in Chinese Investments: EBC Financial Group (UK) Ltd CEO David Barrett Shares Insights with Yi Cai
June 05, 2024 04:50 ET | EBC Financial Group
EBC Financial Group (UK) Ltd CEO David Barrett explores why major investors are drawn to Chinese markets and shares his outlook on their future growth.
July 30, 2021 - ROSEN LOGO.jpg
AXTI SHAREHOLDER ALERT: ROSEN, THE FIRST FILING FIRM, Encourages AXT, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AXTI
May 27, 2024 17:17 ET | The Rosen Law Firm PA
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AXT, Inc. (NASDAQ: AXTI) between March 24, 2021 and April...